雜志介紹

Journal Of Affective Disorders雜志介紹

《Journal Of Affective Disorders》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱情感障礙雜志，本刊主要出版、報(bào)道醫(yī)學(xué)-CLINICAL NEUROLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫SCIE、SSCI收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為4.9，最新CiteScore 指數(shù)為10.9。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Altered brain activity and childhood trauma in Chinese adolescents with borderline personality disorder

  Author: Xiao, Qian; Yi, Xiaoping; Fu, Yan; Jiang, Furong; Zhang, Zhejia; Huang, Qinlin; Han, Zaide; Chen, Bihong T.

• Serum metabolomic profiling revealed potential diagnostic biomarkers in patients with panic disorder

  Author: Shan, Dandan; You, Linlin; Wan, Xuerui; Yang, Huan; Zhao, Meng; Chen, Suzhen; Jiang, Wenhao; Xu, Qian; Yuan, Yonggui

• Association between antenatal depression and adverse perinatal outcomes: a prospective cohort study

  Author: Zhang, Zhi-Yin; Yu, Jing-Jing; Zeng, Wan-Ting; Zhou, Min-Cong; Duan, Chen-Chi; Zhu, Lin-Ling

• The prevalence of depression and suicidal ideation among cancer patients in mainland China and its provinces, 1994-2021: A systematic review and meta-analysis of 201 cross-sectional studies

  Author: Ding, Xiaoping; Wu, Minge; Zhang, Yingying; Liu, Yilan; Han, Yanhong; Wang, Gang; Xiao, Guangqin; Teng, Fen; Wang, Jiaqing; Chen, Jie; Zhang, Wei; Cai, Meijie; Zhang, Yan; Zhou, Su; Hu, Deying

英文介紹

Journal Of Affective Disorders雜志英文介紹

The Journal of Affective Disorders publishes papers concerned with affective disorders in the widest sense: depression, mania, mood spectrum, emotions and personality, anxiety and stress. It is interdisciplinary and aims to bring together different approaches for a diverse readership. Top quality papers will be accepted dealing with any aspect of affective disorders, including neuroimaging, cognitive neurosciences, genetics, molecular biology, experimental and clinical neurosciences, pharmacology, neuroimmunoendocrinology, intervention and treatment trials.